Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Discovery of cyanocarbonimidodithioates as novel non-hydroxamate zinc-binding groups for selective HDAC8 inhibition: Design, synthesis, biological evaluation, anticancer activity, and in silico studies. | Bioorg Chem | 2026 | 42767177 | PubTator, text mining | PubMed |
| Accelerating HDAC8 inhibitor discovery through deep learning, cheminformatics, docking, and molecular dynamics simulations. | J Mol Graph Model | 2026 | 42732699 | PubTator, text mining | PubMed |
| Design, synthesis, and screening of novel thienopyrimidine derivatives as PI3K/HDAC dual inhibitors against cervical cancer cells. | Eur J Med Chem | 2026 | 42715866 | PubTator, text mining | PubMed |
| Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis. | Exp Hematol Oncol | 2026 | 42706582 | PubTator, text mining | PubMed |
| Evaluation of HDAC8 as a Druggable Target in STAG2-Mutant Ewing Sarcoma. | ACS Chem Biol | 2026 | 42677456 | PubTator, text mining | PubMed |
| Fast-Food Component-Induced Epigenetic Modifications Modulate Immunotherapy in Metastatic Breast Cancer. | ACS Omega | 2026 | 42662312 | PubTator, text mining | PubMed |
| Expression of HDAC2 and HDAC8 in the airways of COPD patients is associated with responsiveness to ICS: insights from the HISTORIC study. | Eur Respir J | 2026 | 42660606 | PubTator, text mining | PubMed |
| Design, one-pot synthesis, and structural characterization of novel 2-ureido-6-nitrobenzamide derivatives as MTDLs targeting HDAC8/epigenetic-kinase networks. | Bioorg Chem | 2026 | 42641237 | PubTator, text mining | PubMed |
| Exploration of non-hydroxamate based quinoline analogues as HDAC8 inhibitors. | RSC Adv | 2026 | 42614841 | PubTator, text mining | PubMed |
| Fusion-subtype and single-cell analyses refine the interpretation of HDAC8 dependency in KMT2A-rearranged AML. | Leukemia | 2026 | 42567883 | PubTator, text mining | PubMed |
| Preimplantation Genetic Testing for Cornelia de Lange Syndrome with Low-Level Maternal Gonadal Mosaicism for a Sub-Megabase Deletion in China. | Appl Clin Genet | 2026 | 42502680 | PubTator, text mining | PubMed |
Retraction notice to "lncRNA ENST000000454471 promotes lung adenocarcinoma progression and tumor immune escape: Protein structure and biological functions of histone deacetylase 8" [Int. J. Biol. Macromol. 303 (2025) 140664]. | Int J Biol Macromol | 2026 | 42481332 | PubTator, text mining | PubMed |
| Synthesis, in vitro and in silico studies of transition metal complexes of chrysin with potent anticancer activity via GSK3β phosphorylation, modulation of p38 MAPK pathway and HDAC8 inhibition. | Bioorg Chem | 2026 | 42468084 | PubTator, text mining | PubMed |
| A novel quinoline-based synthetic zinc ionophore regulates Class I HDAC-associated host antiviral response against Newcastle disease virus replication. | Vet Microbiol | 2026 | 42462664 | PubTator, text mining | PubMed |
| TRiC-assisted folding of class I HDAC family proteins regulated by distinct co-chaperone and cofactor networks. | Sci Adv | 2026 | 42455925 | PubTator, text mining | PubMed |
| Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors. | RSC Med Chem | 2026 | 42445800 | PubTator, text mining | PubMed |
| Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity. | J Med Chem | 2026 | 42406494 | PubTator, text mining | PubMed |
| Revisiting the Radical Quenching Activity of Ebselen Analogues in Homogeneous Phase and In Silico Anti-ferroptotic Activity with Histone Deacetylase. | Chembiochem | 2026 | 42405445 | PubTator, text mining | PubMed |
| Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia. | Nat Commun | 2026 | 42277036 | PubTator, text mining | PubMed |
| Aberrant Splicing From an HDAC8 Intronic Variant c.112-15C>A Causes Familial Cornelia de Lange Syndrome in Heterozygous and Hemizygous Individuals. | Congenit Anom (Kyoto) | 2026 | 42157730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers